Acetyl-sulfisoxazole | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Acetyl-sulfisoxazole | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Acetyl-sulfisoxazole | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
Acetyl-sulfisoxazole | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Acetyl-sulfisoxazole | hsa04014 | Ras signaling pathway | 7.30E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04015 | Rap1 signaling pathway | 6.14E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04024 | cAMP signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04071 | Sphingolipid signaling pathway | 9.70E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | |
Acetyl-sulfisoxazole | hsa04140 | Autophagy - animal | 3.72E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | |
Acetyl-sulfisoxazole | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
Acetyl-sulfisoxazole | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.57E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04370 | VEGF signaling pathway | 3.60E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04371 | Apelin signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04380 | Osteoclast differentiation | 2.11E-03 | 2 | Q9NQC7, P31751 | CYLD, AKT2 | More | |
Acetyl-sulfisoxazole | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
Acetyl-sulfisoxazole | hsa04612 | Antigen processing and presentation | 2.84E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
Acetyl-sulfisoxazole | hsa04613 | Neutrophil extracellular trap formation | 1.32E-03 | 14 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | |
Acetyl-sulfisoxazole | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | |
Acetyl-sulfisoxazole | hsa04625 | C-type lectin receptor signaling pathway | 1.38E-05 | 3 | Q9NQC7, P31751, P0DP23 | CYLD, AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04640 | Hematopoietic cell lineage | 3.58E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | |
Acetyl-sulfisoxazole | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | |
Acetyl-sulfisoxazole | hsa04658 | Th1 and Th2 cell differentiation | 1.48E-02 | 7 | Q04759, P20963, P09693, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, STAT4, GATA3, TBX21, HLA-DOB | More | |
Acetyl-sulfisoxazole | hsa04660 | T cell receptor signaling pathway | 3.19E-03 | 10 | P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191 | TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB | More | |
Acetyl-sulfisoxazole | hsa04662 | B cell receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04664 | Fc epsilon RI signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04672 | Intestinal immune network for IgA production | 1.66E-02 | 3 | P10747, P13765, P13612 | CD28, HLA-DOB, ITGA4 | More | |
Acetyl-sulfisoxazole | hsa04722 | Neurotrophin signaling pathway | 2.83E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04728 | Dopaminergic synapse | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04740 | Olfactory transduction | 2.41E-02 | 1 | P0DP23 | CALM1 | More | |
Acetyl-sulfisoxazole | hsa04744 | Phototransduction | 1.81E-02 | 1 | P0DP23 | CALM1 | More | |
Acetyl-sulfisoxazole | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
Acetyl-sulfisoxazole | hsa04915 | Estrogen signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
Acetyl-sulfisoxazole | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04924 | Renin secretion | 1.03E-02 | 4 | P22694, P07550, Q14643, P0DP23 | PRKACB, ADRB2, ITPR1, CALM1 | More | |
Acetyl-sulfisoxazole | hsa04927 | Cortisol synthesis and secretion | 1.66E-02 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | |
Acetyl-sulfisoxazole | hsa04929 | GnRH secretion | 1.81E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa04940 | Type I diabetes mellitus | 3.64E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | |
Acetyl-sulfisoxazole | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Acetyl-sulfisoxazole | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
Acetyl-sulfisoxazole | hsa04970 | Salivary secretion | 1.31E-02 | 5 | P07550, P22694, Q14643, P0DP23, P49913 | ADRB2, PRKACB, ITPR1, CALM1, CAMP | More | |
Acetyl-sulfisoxazole | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
Acetyl-sulfisoxazole | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05010 | Alzheimer disease | 8.59E-04 | 3 | Q00535, P0DP23, P31751 | CDK5, CALM1, AKT2 | More | |
Acetyl-sulfisoxazole | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-02 | 2 | Q00535, P0DP23 | CDK5, CALM1 | More | |
Acetyl-sulfisoxazole | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | |
Acetyl-sulfisoxazole | hsa05031 | Amphetamine addiction | 4.78E-02 | 1 | P0DP23 | CALM1 | More | |
Acetyl-sulfisoxazole | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
Acetyl-sulfisoxazole | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Acetyl-sulfisoxazole | hsa05144 | Malaria | 6.79E-03 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | |
Acetyl-sulfisoxazole | hsa05146 | Amoebiasis | 1.48E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | |
Acetyl-sulfisoxazole | hsa05152 | Tuberculosis | 9.92E-03 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
Acetyl-sulfisoxazole | hsa05163 | Human cytomegalovirus infection | 1.21E-02 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa05170 | Human immunodeficiency virus 1 infection | 6.71E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa05200 | Pathways in cancer | 3.07E-02 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |
Acetyl-sulfisoxazole | hsa05202 | Transcriptional misregulation in cancer | 1.78E-03 | 16 | Q15532, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, LYL1, GADD45A | More | |
Acetyl-sulfisoxazole | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05212 | Pancreatic cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05213 | Endometrial cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05214 | Glioma | 5.75E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | |
Acetyl-sulfisoxazole | hsa05218 | Melanoma | 3.01E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05220 | Chronic myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05223 | Non-small cell lung cancer | 2.41E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05226 | Gastric cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | |
Acetyl-sulfisoxazole | hsa05310 | Asthma | 1.66E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | |
Acetyl-sulfisoxazole | hsa05321 | Inflammatory bowel disease | 1.14E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | |
Acetyl-sulfisoxazole | hsa05323 | Rheumatoid arthritis | 1.58E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | |
Acetyl-sulfisoxazole | hsa05332 | Graft-versus-host disease | 2.03E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | |
Acetyl-sulfisoxazole | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
Acetyl-sulfisoxazole | hsa05418 | Fluid shear stress and atherosclerosis | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | |